NO305555B1 - Kondenserte indan-derivater og farmas°ytisk akseptable salter derav, preparat og anti-tumormiddel - Google Patents

Kondenserte indan-derivater og farmas°ytisk akseptable salter derav, preparat og anti-tumormiddel

Info

Publication number
NO305555B1
NO305555B1 NO960239A NO960239A NO305555B1 NO 305555 B1 NO305555 B1 NO 305555B1 NO 960239 A NO960239 A NO 960239A NO 960239 A NO960239 A NO 960239A NO 305555 B1 NO305555 B1 NO 305555B1
Authority
NO
Norway
Prior art keywords
group
substituted
optionally substituted
ring
pharmaceutically acceptable
Prior art date
Application number
NO960239A
Other languages
English (en)
Other versions
NO960239L (no
NO960239D0 (no
Inventor
Shinji Okazaki
Tetsuji Asao
Motoji Wakida
Keisuke Ishida
Masato Washinosu
Teruhiro Utsugi
Yuji Yamada
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of NO960239D0 publication Critical patent/NO960239D0/no
Publication of NO960239L publication Critical patent/NO960239L/no
Publication of NO305555B1 publication Critical patent/NO305555B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/18Ring systems of four or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
NO960239A 1994-05-20 1996-01-19 Kondenserte indan-derivater og farmas°ytisk akseptable salter derav, preparat og anti-tumormiddel NO305555B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10719094 1994-05-20
PCT/JP1995/000944 WO1995032187A1 (fr) 1994-05-20 1995-05-18 Nouveau derive d'indane fusionne et sel dudit derive acceptable pharmaceutiquement

Publications (3)

Publication Number Publication Date
NO960239D0 NO960239D0 (no) 1996-01-19
NO960239L NO960239L (no) 1996-03-18
NO305555B1 true NO305555B1 (no) 1999-06-21

Family

ID=14452758

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960239A NO305555B1 (no) 1994-05-20 1996-01-19 Kondenserte indan-derivater og farmas°ytisk akseptable salter derav, preparat og anti-tumormiddel

Country Status (21)

Country Link
US (3) US5733918A (no)
EP (1) EP0713870B1 (no)
KR (1) KR100190732B1 (no)
CN (1) CN1131216C (no)
AT (1) ATE203236T1 (no)
AU (1) AU685631B2 (no)
CA (1) CA2167382C (no)
DE (1) DE69521770T2 (no)
DK (1) DK0713870T3 (no)
ES (1) ES2158109T3 (no)
FI (1) FI111721B (no)
GR (1) GR3036795T3 (no)
HU (1) HU218308B (no)
IL (1) IL113778A (no)
NO (1) NO305555B1 (no)
NZ (1) NZ285448A (no)
PT (1) PT713870E (no)
RU (1) RU2124017C1 (no)
TW (1) TW440562B (no)
WO (1) WO1995032187A1 (no)
ZA (1) ZA954077B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3141148B2 (ja) * 1995-08-08 2001-03-05 大鵬薬品工業株式会社 縮合インダン誘導体及びその塩
US6956035B2 (en) * 2001-08-31 2005-10-18 Inotek Pharmaceuticals Corporation Isoquinoline derivatives and methods of use thereof
US20030096833A1 (en) * 2001-08-31 2003-05-22 Jagtap Prakash G. Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof
ATE316971T1 (de) * 2001-10-05 2006-02-15 Hoffmann La Roche Polycyclische verbindungen mit antitumor-wirkung
US6946472B2 (en) 2002-04-30 2005-09-20 Hoffman-La Roche Inc. Polycyclic compounds exhibiting anti-tumor activities
CL2004000366A1 (es) * 2003-02-26 2005-01-07 Pharmacia Corp Sa Organizada B USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA.
BRPI0407757A (pt) * 2003-02-28 2006-02-14 Inotek Pharmaceuticals Corp derivados de benzamida tetracìclica e métodos de uso dos mesmos
EP1722797A4 (en) * 2004-02-26 2008-03-19 Inotek Pharmaceuticals Corp ISOCHINOLINE DERIVATIVES AND METHOD FOR THE APPLICATION THEREOF
JP2007525526A (ja) * 2004-02-26 2007-09-06 イノテック ファーマシューティカルズ コーポレイション 四環系ラクタム誘導体およびその使用
US20060019980A1 (en) * 2004-06-16 2006-01-26 Inotek Pharmaceutical, Corp. Methods for treating or preventing erectile dysfunction or urinary incontinence
CN101128431B (zh) * 2005-02-24 2011-05-25 詹森药业有限公司 作为钾离子通道打开剂的喹啉衍生物
JP2008531563A (ja) * 2005-02-25 2008-08-14 イノテック ファーマシューティカルズ コーポレイション 四環スルホンアミド化合物およびこれらの使用法
US7381722B2 (en) * 2005-02-25 2008-06-03 Inotek Pharmaceuticals Corporation Tetracyclic amino and carboxamido compounds and methods of use thereof
AU2006219022A1 (en) * 2005-02-25 2006-09-08 Inotek Pharmaceuticals Corporation Isoqunoline Compounds and methods of use thereof
KR20080039508A (ko) * 2005-08-24 2008-05-07 이노텍 파마슈티컬스 코포레이션 인데노이소퀴놀리논 유사체 및 이의 사용 방법
CA2677046A1 (en) * 2007-02-28 2008-09-04 Inotek Pharmaceuticals Corporation Indenoisoquinolinone analogs and methods of use thereof
CN103102304B (zh) * 2013-01-19 2015-03-11 安徽师范大学 N-磺酰基取代四氢异喹啉衍生物的制备方法
HUE034807T2 (en) 2013-08-22 2018-02-28 Taiho Pharmaceutical Co Ltd New quinoline-substituted compound
JOP20190073A1 (ar) 2016-10-31 2019-04-07 Taiho Pharmaceutical Co Ltd مثبط انتقائي لمستقبل عامل نمو بشروي (egfr) لطافر إدخال exon 20
JOP20200044A1 (ar) 2017-09-01 2020-02-26 Taiho Pharmaceutical Co Ltd مثبط انتقائي egfr طافر exon 18 و/أو exon 21

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223506A (en) * 1991-06-04 1993-06-29 Glaxo Inc. Cyclic antitumor compounds

Also Published As

Publication number Publication date
EP0713870B1 (en) 2001-07-18
FI960280A (fi) 1996-03-18
ZA954077B (en) 1996-01-19
CN1131216C (zh) 2003-12-17
CA2167382A1 (en) 1995-11-30
ES2158109T3 (es) 2001-09-01
DE69521770T2 (de) 2002-05-23
NO960239L (no) 1996-03-18
WO1995032187A1 (fr) 1995-11-30
FI111721B (fi) 2003-09-15
FI960280A0 (fi) 1996-01-19
CA2167382C (en) 1999-08-31
IL113778A0 (en) 1995-08-31
HUT75651A (en) 1997-05-28
US5733918A (en) 1998-03-31
GR3036795T3 (en) 2002-01-31
PT713870E (pt) 2001-11-30
DE69521770D1 (de) 2001-08-23
RU2124017C1 (ru) 1998-12-27
ATE203236T1 (de) 2001-08-15
KR960703864A (ko) 1996-08-31
US5710162A (en) 1998-01-20
TW440562B (en) 2001-06-16
DK0713870T3 (da) 2001-09-24
AU2454295A (en) 1995-12-18
US6028079A (en) 2000-02-22
AU685631B2 (en) 1998-01-22
HU218308B (en) 2000-07-28
CN1130903A (zh) 1996-09-11
NO960239D0 (no) 1996-01-19
EP0713870A1 (en) 1996-05-29
EP0713870A4 (en) 1996-12-18
NZ285448A (en) 1997-11-24
KR100190732B1 (ko) 1999-06-01
IL113778A (en) 1999-09-22

Similar Documents

Publication Publication Date Title
NO305555B1 (no) Kondenserte indan-derivater og farmas°ytisk akseptable salter derav, preparat og anti-tumormiddel
NO20015448D0 (no) Kinolinderivater som inhibitorer av MEK enzymer
ATE116964T1 (de) Substituierte aminoalkylbiphenylderivate, antimykotische präparate damit und zwischenprodukte für ihre herstellung.
DE68906183T2 (de) 2'-desoxy-5-fluoruridinderivate.
ATE205199T1 (de) Quinolin- oder quinazolinderivate, deren herstellung und verwendung
DE69311165T2 (de) Kondensierte heterocyclische Ketonderivate, ihre Herstellung und ihre Verwendung
IE862630L (en) 3-VINYL AND 3-ETHYNYL-ß-CARBOLINES
AU6158486A (en) Dihydro pyridine derivatives
KR950704333A (ko) 신규한 세펨 유도체(novel cephem derivatives)
DE69624459T2 (de) Kondensierte indan-derivate und ihre salze
DE69634004D1 (de) Verknüpfte polycyclische heterocyclische verbindungen
ATE180251T1 (de) Indan derivate und verfahren zu deren herstellung
CA2202031A1 (en) Condensed indan derivatives and salts thereof
PL342826A1 (en) Derivatives of cycloalkenes, their production and application